A physiological role of interferon (IFN)-beta derived from tumor: tumor growth of a mouse bladder carcinoma line MBT-2 is partially suppressed by autocrine IFN-beta

Cancer Lett. 1997 Feb 26;113(1-2):159-64. doi: 10.1016/s0304-3835(96)04594-6.

Abstract

Although some tumor cells endogenously produce a wide variety of cytokines, their physiological roles remain to be fully understood. In this study, we found that mouse subcutaneous tumor induced by inoculation of bladder tumor MBT-2 cells into syngeneic mice secreted a significant amount of interferon (IFN), whereas the cells exhibited no IFN production in in vitro cell culture. Typing experiment using IFN-specific neutralizing antibodies showed that the tumor-derived IFN was exclusively beta type. Since the MBT-2 tumor tissues were homogenous and not infiltrated by immune cells, MBT-2 cells themselves were considered to be IFN-beta producers. By intraperitoneal injection of neutralizing anti-IFN-beta antibodies into MBT-2 cell-inoculated mice, the tumor growth was substantially precipitated and survival days of the tumor-bearing mice were shortened. As the in vitro cell growth of MBT-2 cells was dose-dependently inhibited by IFN-beta, it was suggested that apparent immunogenicity of MBT-2 tumor is partially mediated by tumor suppression by autocrine IFN-beta.

MeSH terms

  • Animals
  • Antibodies, Monoclonal
  • Antineoplastic Agents / analysis*
  • Antineoplastic Agents / immunology
  • Antineoplastic Agents / pharmacology
  • Dose-Response Relationship, Drug
  • Female
  • Interferon-beta / immunology
  • Interferon-beta / pharmacology
  • Interferon-beta / physiology*
  • Mice
  • Mice, Inbred C3H
  • Neoplasm Transplantation
  • Tumor Cells, Cultured / drug effects
  • Urinary Bladder Neoplasms / chemistry*
  • Urinary Bladder Neoplasms / mortality
  • Urinary Bladder Neoplasms / pathology

Substances

  • Antibodies, Monoclonal
  • Antineoplastic Agents
  • Interferon-beta